Manila Times Business
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development
SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and PreventionSK bioscience is jointly investing with the RIGHT Foundation to drive process development that enhances both efficacy and productivity"We are committed to improving public health through continuous innovation and global partnership."INCHEON, South Korea, June 9, 2026 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Bata, Django, De la Cruz lead coaching staff of new billiards NSA
2h ago
Tokenized Cash Management Advisory Group Publishes the Scope of Its Work Program
2h ago
COSMOBEAUTÉ MALAYSIA & BEAUTYEXPO 2026 RETURNS TO KLCC TO DRIVE B2B EXCELLENCE AND NEW BUSINESS FRONTIERS
2h ago
Regent Hong Kong Named Among First-Ever Winners of Condé Nast Traveler's Triple Crown Award
2h ago